Eric Topol hails AI trial methods covered by NYT: "exciting if confirmed"
EricTopol · x · 2026-09-07
Eric Topol amplified a NYT (Cade Metz) story on AI methods in medical trials, calling it exciting especially if confirmed in larger independent studies. Researcher @DrBischof says "these are methods we will use in future trials," involving organ clock and drug dose effects.
Related event: AI-designed drug shows early signs of reversing biological age(7 posts)→
More from Research
- Transformers Laid Out: A Single Tutorial Unifying Intuition, the Paper, and PyTorch Code — goyal__pramod · 2026-09-07
- Multi-agent clinical decision support system with patient similarity retrieval on MIMIC-IV — kshameer · 2026-09-07
- Primer: the role of health digital twins in oncology drug development — kshameer · 2026-09-07
- In Science Labs, 200 Data Points Often Need a Gaussian Process, Not Deep Learning — bravo_abad · 2026-09-07
- Confidence scores aren't assays: a guide to evaluating protein-structure AI claims — Fair-Rain3366 · 2026-09-07
- Distilling From Smart General Models Beats Human Annotation for Cheap Narrow AI — ricklamers · 2026-09-07